Dr Reddys Laboratories (RDY) Net Margin (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded Net Margin of 5.50% in the quarter ended Jun 30, 2026, down 11.10 percentage points from 16.59% a year earlier and down 9750.90 percentage points from the prior quarter.
Dr Reddys Laboratories (RDY) Net Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' Net Margin came in at 4658.34% as of Jun 30, 2026, up 2338.93 percentage points year-over-year; for the year ended Mar 31, 2026, it came in at 12.74%, down 8747.61 percentage points from the prior year.
- Annual Net Margin has a five-year change of +0.14 percentage points (years ended Mar 2021 to Mar 2026).
- Across earlier years, Net Margin came in at 8760.35% in the year ended Mar 31, 2025 (+8740.27 pp), 20.08% in the year ended Mar 31, 2024 (+1.31 pp), 18.77% in the year ended Mar 31, 2023 (+4.77 pp) and 14.00% in the year ended Mar 31, 2022 (+1.41 pp).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Net Margin since the quarter ended Mar 31, 2022.
- On a year-over-year basis, Net Margin rose in four of the last eight quarters, with an average year-over-year change of +2362.96 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 9192.69 percentage points in the quarter ended Mar 31, 2025, against a drop of 11.10 percentage points in the quarter ended Jun 30, 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 9756.40% (quarter ended Mar 31, 2026), 9206.57% (quarter ended Dec 31, 2025) and 19.89% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn | 5.50% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.50% |
| Mar 31, 2026 | 9,756.40% |
| Dec 31, 2025 | 9,206.57% |
| Sep 30, 2025 | 19.89% |
| Jun 30, 2025 | 16.59% |
| Mar 31, 2025 | 9,213.81% |
| Dec 31, 2024 | 22.40% |
| Sep 30, 2024 | 21.89% |
| Jun 30, 2024 | 18.14% |
| Mar 31, 2024 | 21.12% |
| Dec 31, 2023 | 23.93% |
| Sep 30, 2023 | 21.51% |
| Jun 30, 2023 | 25.93% |
| Mar 31, 2023 | 18.57% |
| Dec 31, 2022 | 26.08% |
| Sep 30, 2022 | 24.55% |
| Jun 30, 2022 | 23.42% |
| Mar 31, 2022 | 2.79% |
| Dec 31, 2021 | 17.19% |
| Sep 30, 2021 | 23.32% |
Dr Reddys Laboratories Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();